By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Optivia Biotechnology Inc. 

115 Constitution Drive
Suite 7
Menlo Park  California  94025  U.S.A.
Phone: 650-324-3177 Fax: 650-324-1855



Company News
Optivia Biotechnology Inc. Launches Screening Service For Transporters As Drug Targets 9/15/2015 3:18:48 PM
Optivia Biotechnology Inc. Appoints Dr. Jean-Michel Scherrmann To Scientific Advisory Board 2/11/2015 12:53:15 PM
Optivia Biotechnology Inc. Awarded $1.8 Million SBIR Grant to Build Platform for Transforming Central Nervous System (CNS) Disease Drug Discovery and Development 10/2/2013 9:38:47 AM
Optivia Biotechnology Inc. Wins CRO Leadership Award from Life Science Leader 6/4/2012 10:54:21 AM
Optivia Biotechnology Inc. Awarded $1.85 Million SBIR Grant to Build Comprehensive Platform for Assessing Dangerous Drug-Drug Interactions 4/5/2011 10:45:33 AM
Almost 300 New Jobs To Be Created By Three Pharma Firms: Optivia Biotechnology Inc., Global Research Services, LLC, and International Prevention Research Institute (iPRI) 3/16/2011 6:06:04 PM
Optivia Biotechnology Inc. Signs Agreement With U.S. FDA to Assess Role of Dietary Supplements in Drug-Induced Liver Injury 2/1/2011 9:00:33 AM
University of California, San Francisco (UCSF) and Optivia Biotechnology Inc. Collaborate to Predict Liver Toxicity of Drugs in Development 11/16/2010 9:57:40 AM
Optivia Biotechnology Inc. Names Dr. Yuichi Sugiyama to Scientific Advisory Board 11/15/2010 11:59:26 AM
Optivia Biotechnology Inc. Launches Comprehensive Assay Suite to Assess Transporter-Related Drug-Drug Interactions and Improve Drug Safety 5/11/2010 11:15:17 AM